The McGill University Department of Pathology is located in the Duff Medical Building on the downtown University campus at the edge of splendid Mount Royal. The Department offers research training in a wide variety of areas such as carcinogenesis, mechanisms of respiratory diseases, molecular pathology and immunology, neoplasia and cell biology, cell differentiation, cell adhesion molecules, biomedical image processing, neurodegenerative disorders and opthalmic pathology. Research laboratories are located in the Duff Medical Building, the Research Institute of the McGill University Health Centre and McGill Teaching Hospitals.
We are pleased to announce the appointment of Lili-Naz Hazrati, MD, PhD, as Chair of the Department of Pathology, Faculty of Medicine and Health Sciences (FMHS), McGill University, effective August 1, 2023.
Before studying medicine, Dr. Hazrati obtained her BSc in Biology-Physiology, and an MSc and PhD in Neurobiology at Université Laval followed by post-doctoral work in Neuroscience at Yale University. She then attended Université de Montréal where she obtained her MD and completed further post-doctoral work in Neuroscience. Dr. Hazrati then did her residency in Neuropathology as well as a clinical research fellowship at the University of Toronto. During this time, she was also an Invited Scientist in Neurodegeneration at the University of Pennsylvania.
Prior to accepting her new appointment at McGill, Dr. Hazrati was Associate Professor, Laboratory Medicine and Pathobiology at the University of Toronto, and a staff neuropathologist at The Hospital for Sick Children, Toronto. For the past several years, she has been an Associate Scientist, Mental Health and Neuroscience at SickKids Research Institute. She also previously held positions as a staff neuropathologist in the University Health Network-Toronto, and as a principal investigator at the Tanz Centre for Research in Neurodegenerative Diseases at the University of Toronto.
Dr. Hazrati is highly regarded for her research on the long-term effects of head trauma as well as other factors contributing to later-life neurodegenerative disease. As a principal investigator, she currently holds a Canadian Institutes of Health Research (CIHR) grant titled Long-term Effects of Mild Traumatic Brain Injury through Premature Cellular Senescence. She was a co-investigator on the recently completed CIHR-funded study Contribution of Mid-life Comorbidities to Alzheimer’s. She is also involved in two studies funded by the National Institutes of Health including as co-investigator of the Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive Decline – Center Without Walls study.
Dr. Hazrati is a member of several networks and working groups to set standards of practice and diagnostic criteria including the Canadian Traumatic Brain Injury Research Consortium, and The Collaborative Neuropathology Network. She is a member of numerous professional organizations including the Canadian Association of Pathologists, American Association of Pathologists, the American Association of Neuropathology and the International Brain Research Organization. For the past decade, she has acted as Neuropathology consultant for both the Ontario and Quebec provincial forensic units.
Dr. Hazrati’s education and teaching activities include the National Pediatric Pathology network resident training, and she also designed and implemented online teaching for the Pathology Residency Program at Memorial University. She currently serves as Chair, Neuropathology Exam Board for the Royal College of Physicians and Surgeons of Canada. She is the author of 110 peer-reviewed articles and has given interviews for numerous books and media outlets both in Canada and abroad.
As Chair of the Department of Pathology, Dr. Hazrati will direct the academic activities of the Department including on-campus research. She will oversee the Department’s undergraduate and postgraduate programs, as well as recruitment and the promotion of pathology services across all the McGill-affiliated academic institutions. She will make recommendations and advise the Dean on academic recruitment, appointments, promotion and tenure.
Please join us in congratulating Dr. Hazrati on her appointment and in wishing her every success in her new role.
July 19, 2023: Congratulations to Dr. Julia Burnier. McGill University and Moderna are expanding collaborations with new projects in Lipid Nanoparticle research, Dr. Julia Burnier, Assistant Professor of Pathology is investigating ways to enhance the cell-specific delivery of cargo like mRNA. Extracellular vesicles (EVs) are naturally occurring nanoparticles that are released by virtually all cells and can deliver cargo to specific cells. Her research aims to develop a cell delivery system using microfluidics that emulates the activity of EVs, which could help optimize delivery to targeted recipient cells. This offers the possibility of developing therapies beyond vaccines, such as in precision oncology and other illnesses. The project is scheduled to run for three years.
Spring Convocation was very special this year - nine of our graduate students received their degrees, and three members of the department were involved in the ceremony. Prisca Bustamante, Constanza Martinez-Ramirez, Shaida Ouladan and Mahbuba Subeha received PhDs, while Aeshah Alluli, Luc Boulianne, Tadhg Ferrier, Alexander Laskaris and Matthew Preteroti received MScs. Prof Edith Zorychta is the university Co-Marshal, and Prof Carlos Telleria and Dr. Hua Ling were Faculty Marshals for Medicine and Health Sciences. Some of us managed to find each other among the thousands of happy people celebrating on the campus after the ceremony, and it was wonderful to be together for a photo. It was also a great pleasure to be on the stage with our graduates as they received their degrees.
The past two years have been challenging, and our Pathology Student Society (PSS) has been strongly involved in maintaining community spirit. PSS normally organizes events that allow graduate students to connect and share their common scientific interests, and to enjoy being together for social activities. During the pandemic there were limited options for in-person events but PSS managed to organize one every semester. In fall they arranged a group hike up to the Mont-Royal observatory. Since many students come from abroad, PSS wanted to highlight a destination that is special for all Montrealers. They started from the Peel St. entrance near campus and ended at Beaver Lake at dusk to watch the sunset with some pumpkin spice lattes. The end of the winter semester was celebrated with a small get-together at McGill’s very own graduate center, Thomson House. PSS had an entire lounge booked with complementary food and drinks. A fun-filled night with great company and hopefully many more to come.
- Published: 3 Oct 2023
- Published: 21 Jun 2021
- Published: 20 May 2021
Drs Spatz, Fiset, Wang, and Camilleri-Broet from the Department of Pathology are at the core of the innovative research project “The Karen Anthony Consortium for Lung Cancer Research”Published: 2 Oct 2020
Dr. Miguel Burnier has been appointed the Interim Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre (RI-MUHC)Published: 24 Aug 2020
Our PhD student Christina Mastromonaco is a pioneer in the Life Sciences Entrepreneurship Development Program at ConcordiaPublished: 6 Nov 2019
- Published: 2 Oct 2019
- Published: 2 Jul 2019
- Published: 2 Jul 2019
Congratulations to Professor Alan Spatz on receiving GAPP-Genome Canada and Cancer Research Society grantsPublished: 10 Dec 2018
McGill Case of the month
Current Case of the Month February 2023
Previous Case of the Month
Publication of the month
Farah H. Abdalbari; Elvis Martinez-Jaramillo ...Carlos M. Telleria: Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells. Cancers 2023, 15, 5136. https://doi.org/10.3390/
Sarah Tadhg Ferrier,Thupten Tsering, Nader Sadeghi, Anthony Zeitouni, Julia V. Burnier: Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer. Cancer Medicine V12(15) Agu 2023
Tsering T,Li MY,Chen YX, Nadeau A, Laskaris A, Abdouh M, Bustamante P, Burnier JV:
Julien LA, Michel RP, Auger M : Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology. Cancer Cytopathol. 2020 Jan 3.
Pusztaszeri MP, Bongiovanni M, Brimo F: Do we need PD-L1 as a biomarker for thyroid cytologic and histologic specimens? Cancer Cytopathol. 2019 Dec 10
Bustamante P1... Burnier JV. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma. Cancer Med. 2019 Oct 7.
Ferreira SR...: Prenatally androgenized female rats develop uterine hyperplasia when adult. Mol Cell Endocrinol. 2019 Oct 4:110610.
Sharifi Z...Sabri S: Antitumor Activity of a Binary EGFR/DNA Targeting Strategy Overcomes Resistance of Glioblastoma Stem cells to Temozolomide. Clin Cancer Res. 2019 Sep 20.